Gallstones

Frank Lammert, Kurinchi Gurusamy, Cynthia W. Ko, Juan Francisco Miquel, Nahum Méndez-Sánchez, Piero Portincasa, Karel J. van Erpecum, Cees J. van Laarhoven, David Q.H. Wang

Research output: Contribution to journalReview article

50 Citations (Scopus)

Abstract

Gallstones grow inside the gallbladder or biliary tract. These stones can be asymptomatic or symptomatic; only gallstones with symptoms or complications are defined as gallstone disease. Based on their composition, gallstones are classified into cholesterol gallstones, which represent the predominant entity, and bilirubin ('pigment') stones. Black pigment stones can be caused by chronic haemolysis; brown pigment stones typically develop in obstructed and infected bile ducts. For treatment, localization of the gallstones in the biliary tract is more relevant than composition. Overall, up to 20% of adults develop gallstones and >20% of those develop symptoms or complications. Risk factors for gallstones are female sex, age, pregnancy, physical inactivity, obesity and overnutrition. Factors involved in metabolic syndrome increase the risk of developing gallstones and form the basis of primary prevention by lifestyle changes. Common mutations in the hepatic cholesterol transporter ABCG8 confer most of the genetic risk of developing gallstones, which accounts for ∼25% of the total risk. Diagnosis is mainly based on clinical symptoms, abdominal ultrasonography and liver biochemistry tests. Symptoms often precede the onset of the three common and potentially life-threatening complications of gallstones (acute cholecystitis, acute cholangitis and biliary pancreatitis). Although our knowledge on the genetics and pathophysiology of gallstones has expanded recently, current treatment algorithms remain predominantly invasive and are based on surgery. Hence, our future efforts should focus on novel preventive strategies to overcome the onset of gallstones in at-risk patients in particular, but also in the population in general.

Original languageEnglish (US)
Number of pages1
JournalNature reviews. Disease primers
Volume2
DOIs
StatePublished - Apr 28 2016
Externally publishedYes

Fingerprint

Gallstones
Biliary Tract
Cholesterol
Overnutrition
Acute Cholecystitis
Cholangitis
Liver
Primary Prevention
Hemolysis
Bile Ducts
Gallbladder
Bilirubin
Pancreatitis
Biochemistry
Life Style
Ultrasonography
Obesity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lammert, F., Gurusamy, K., Ko, C. W., Miquel, J. F., Méndez-Sánchez, N., Portincasa, P., ... Wang, D. Q. H. (2016). Gallstones. Nature reviews. Disease primers, 2. https://doi.org/10.1038/nrdp.2016.24

Gallstones. / Lammert, Frank; Gurusamy, Kurinchi; Ko, Cynthia W.; Miquel, Juan Francisco; Méndez-Sánchez, Nahum; Portincasa, Piero; van Erpecum, Karel J.; van Laarhoven, Cees J.; Wang, David Q.H.

In: Nature reviews. Disease primers, Vol. 2, 28.04.2016.

Research output: Contribution to journalReview article

Lammert, F, Gurusamy, K, Ko, CW, Miquel, JF, Méndez-Sánchez, N, Portincasa, P, van Erpecum, KJ, van Laarhoven, CJ & Wang, DQH 2016, 'Gallstones', Nature reviews. Disease primers, vol. 2. https://doi.org/10.1038/nrdp.2016.24
Lammert F, Gurusamy K, Ko CW, Miquel JF, Méndez-Sánchez N, Portincasa P et al. Gallstones. Nature reviews. Disease primers. 2016 Apr 28;2. https://doi.org/10.1038/nrdp.2016.24
Lammert, Frank ; Gurusamy, Kurinchi ; Ko, Cynthia W. ; Miquel, Juan Francisco ; Méndez-Sánchez, Nahum ; Portincasa, Piero ; van Erpecum, Karel J. ; van Laarhoven, Cees J. ; Wang, David Q.H. / Gallstones. In: Nature reviews. Disease primers. 2016 ; Vol. 2.
@article{df1cfca34ac5458ea1b89798af1e3cbc,
title = "Gallstones",
abstract = "Gallstones grow inside the gallbladder or biliary tract. These stones can be asymptomatic or symptomatic; only gallstones with symptoms or complications are defined as gallstone disease. Based on their composition, gallstones are classified into cholesterol gallstones, which represent the predominant entity, and bilirubin ('pigment') stones. Black pigment stones can be caused by chronic haemolysis; brown pigment stones typically develop in obstructed and infected bile ducts. For treatment, localization of the gallstones in the biliary tract is more relevant than composition. Overall, up to 20{\%} of adults develop gallstones and >20{\%} of those develop symptoms or complications. Risk factors for gallstones are female sex, age, pregnancy, physical inactivity, obesity and overnutrition. Factors involved in metabolic syndrome increase the risk of developing gallstones and form the basis of primary prevention by lifestyle changes. Common mutations in the hepatic cholesterol transporter ABCG8 confer most of the genetic risk of developing gallstones, which accounts for ∼25{\%} of the total risk. Diagnosis is mainly based on clinical symptoms, abdominal ultrasonography and liver biochemistry tests. Symptoms often precede the onset of the three common and potentially life-threatening complications of gallstones (acute cholecystitis, acute cholangitis and biliary pancreatitis). Although our knowledge on the genetics and pathophysiology of gallstones has expanded recently, current treatment algorithms remain predominantly invasive and are based on surgery. Hence, our future efforts should focus on novel preventive strategies to overcome the onset of gallstones in at-risk patients in particular, but also in the population in general.",
author = "Frank Lammert and Kurinchi Gurusamy and Ko, {Cynthia W.} and Miquel, {Juan Francisco} and Nahum M{\'e}ndez-S{\'a}nchez and Piero Portincasa and {van Erpecum}, {Karel J.} and {van Laarhoven}, {Cees J.} and Wang, {David Q.H.}",
year = "2016",
month = "4",
day = "28",
doi = "10.1038/nrdp.2016.24",
language = "English (US)",
volume = "2",
journal = "Nature Reviews Disease Primers",
issn = "2056-676X",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Gallstones

AU - Lammert, Frank

AU - Gurusamy, Kurinchi

AU - Ko, Cynthia W.

AU - Miquel, Juan Francisco

AU - Méndez-Sánchez, Nahum

AU - Portincasa, Piero

AU - van Erpecum, Karel J.

AU - van Laarhoven, Cees J.

AU - Wang, David Q.H.

PY - 2016/4/28

Y1 - 2016/4/28

N2 - Gallstones grow inside the gallbladder or biliary tract. These stones can be asymptomatic or symptomatic; only gallstones with symptoms or complications are defined as gallstone disease. Based on their composition, gallstones are classified into cholesterol gallstones, which represent the predominant entity, and bilirubin ('pigment') stones. Black pigment stones can be caused by chronic haemolysis; brown pigment stones typically develop in obstructed and infected bile ducts. For treatment, localization of the gallstones in the biliary tract is more relevant than composition. Overall, up to 20% of adults develop gallstones and >20% of those develop symptoms or complications. Risk factors for gallstones are female sex, age, pregnancy, physical inactivity, obesity and overnutrition. Factors involved in metabolic syndrome increase the risk of developing gallstones and form the basis of primary prevention by lifestyle changes. Common mutations in the hepatic cholesterol transporter ABCG8 confer most of the genetic risk of developing gallstones, which accounts for ∼25% of the total risk. Diagnosis is mainly based on clinical symptoms, abdominal ultrasonography and liver biochemistry tests. Symptoms often precede the onset of the three common and potentially life-threatening complications of gallstones (acute cholecystitis, acute cholangitis and biliary pancreatitis). Although our knowledge on the genetics and pathophysiology of gallstones has expanded recently, current treatment algorithms remain predominantly invasive and are based on surgery. Hence, our future efforts should focus on novel preventive strategies to overcome the onset of gallstones in at-risk patients in particular, but also in the population in general.

AB - Gallstones grow inside the gallbladder or biliary tract. These stones can be asymptomatic or symptomatic; only gallstones with symptoms or complications are defined as gallstone disease. Based on their composition, gallstones are classified into cholesterol gallstones, which represent the predominant entity, and bilirubin ('pigment') stones. Black pigment stones can be caused by chronic haemolysis; brown pigment stones typically develop in obstructed and infected bile ducts. For treatment, localization of the gallstones in the biliary tract is more relevant than composition. Overall, up to 20% of adults develop gallstones and >20% of those develop symptoms or complications. Risk factors for gallstones are female sex, age, pregnancy, physical inactivity, obesity and overnutrition. Factors involved in metabolic syndrome increase the risk of developing gallstones and form the basis of primary prevention by lifestyle changes. Common mutations in the hepatic cholesterol transporter ABCG8 confer most of the genetic risk of developing gallstones, which accounts for ∼25% of the total risk. Diagnosis is mainly based on clinical symptoms, abdominal ultrasonography and liver biochemistry tests. Symptoms often precede the onset of the three common and potentially life-threatening complications of gallstones (acute cholecystitis, acute cholangitis and biliary pancreatitis). Although our knowledge on the genetics and pathophysiology of gallstones has expanded recently, current treatment algorithms remain predominantly invasive and are based on surgery. Hence, our future efforts should focus on novel preventive strategies to overcome the onset of gallstones in at-risk patients in particular, but also in the population in general.

UR - http://www.scopus.com/inward/record.url?scp=85033364179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033364179&partnerID=8YFLogxK

U2 - 10.1038/nrdp.2016.24

DO - 10.1038/nrdp.2016.24

M3 - Review article

C2 - 27121416

AN - SCOPUS:85033364179

VL - 2

JO - Nature Reviews Disease Primers

JF - Nature Reviews Disease Primers

SN - 2056-676X

ER -